Is SEID Dead?
A recent CDC "phoner" hosted by CDC's Beth Unger included presentations by three members of the IOM committee who prepared the IOM report on ME/CFS. The committee chairwoman Ellen Clayton and doctors Lucinda Bateman and Peter Rowe were asked by an anonymous emailer if they would do anything differently today. All three said they would have dropped the suggestion to rename the disease SEID, (for Systemic Exertion Intolerance Disease). The controversy surrounding the name overshadowed important information for clinicians to enable them to diagnose the disease, the reports' strength.
The Fate and Fortunes of the Lazarus drug, Part Four
What is Ampligen? It turns out Ampligen may well be so much more than a therapy for the pandemic disease ME. Ampligen's manufacturer and patent holder, Hemipsherx Biopharma, is moving forward with plans to repurpose the drug in other diseases , including myriad cancers. Scientists who are experimenting with new uses for the drug discuss their work--and why they think Ampligen could be the next big thing. Bonus content: Tom Equels, Polymath? Last in a series of four articles on the Fate and Fortunes of the Lazarus Drug.